Abstract
Lower serum albumin (sAlb) has been associated with an increased risk of mortality and AIDS among people living with HIV and may be associated with the development of serious non-AIDS events (SNAEs). We evaluated the long-term association between sAlb and the risk of SNAEs. Prospective multinational cohort study. D:A:D participants without SNAEs were followed from first routine sAlb value to the first of a new SNAE [cardiovascular disease (CVD), end-stage liver disease (ESLD), end-stage renal disease (ESRD), non-AIDS malignancy (NADM), death from non-AIDS cause], AIDS-death, 6 months after last visit or 1 February 2016. Poisson regression was used to determine associations between sAlb and a new SNAE, CVD, or NADM event, with adjustment for potential confounders. Models additionally tested whether the associations were modified by age, follow-up time, smoking status, CD4 and viral load. Of 16 350 participants (71.8% male, median age 44 years), 1463 developed an SNAE (371 CVD, 200 ESLD, 40 ESRD, 553 NADM, 299 deaths from other non-AIDS causes) over 80 264 person-years. Increased sAlb was associated with a decreased risk of an SNAE [adjusted rate ratio per 5 g/l: SNAE 0.79 (95% confidence interval: 0.76, 0.83); CVD 0.87 (0.80, 0....Continue Reading
References
Feb 1, 1990·The Biochemical Journal·P C HeinrichT Andus
Apr 6, 1985·Lancet·A FleckK C Calman
Mar 9, 2000·American Journal of Epidemiology·J J NelsonG Heiss
Jun 6, 2000·AIDS·J G FeldmanP Miotti
Nov 9, 2002·Alimentary Pharmacology & Therapeutics·T W Evans
Nov 22, 2002·Lancet·Caroline A SabinChristine A Lee
Feb 5, 2003·The Journal of Experimental Medicine·Chaity ChaudhuryClark L Anderson
May 6, 2004·Journal of Clinical Epidemiology·A Gerald ShaperPeter H Whincup
Jan 6, 2006·IUBMB Life·Mauro FasanoPaolo Ascenzi
Feb 20, 2007·HIV Medicine·S ShahC A Sabin
Aug 22, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Xindong LiuXiaoping Zhu
Jan 16, 2010·Journal of the American Society of Nephrology : JASN·Allon N Friedman, Stephen Z Fadem
May 8, 2010·The Journal of Infectious Diseases·Jacqueline NeuhausJames D Neaton
Apr 26, 2012·PloS One·Jean-Claude DusingizeKathryn Anastos
Jan 16, 2013·The Journal of Infectious Diseases·Christopher R SudfeldWafaie W Fawzi
Jan 25, 2013·AIDS·Joshua LangMichael G Shlipak
Oct 3, 2014·Journal of the National Cancer Institute·Meredith S ShielsAnil K Chaturvedi
Aug 4, 2016·International Journal of General Medicine·David G Levitt, Michael D Levitt
Sep 28, 2016·AIDS·Rebecca ScherzerUNKNOWN Study of Fat Redistribution, Metabolic Change in HIV Infection (FRAM)
Dec 16, 2017·The Journal of Infectious Diseases·Andreas RonitUNKNOWN International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) Strategic Timing of Antiretroviral Treatment